Pay in 4 interest-free payments of $7.44 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Food and Drug Administration (FDA) for weight loss or other off-label uses
Bushnell, D
The rapid advance of brain organoid assembloid technologies (further detailed below), where unique types of organoids are physically connected to permit observation and assessment of neuronal network formation across brain regions, is substantially supporting efforts to improve physiological relevance in neurological disease models
In the unilateral ureteral obstruction (UUO) animal model, the administration of deferoxamine (DFO) has been shown to alleviate tubulointerstitial fibrosis
US$ 25.14
US$ 28.33
US$ 23.57
US$ 24.44
